Prevention of CD18-Mediated Reperfusion Injury Enhances the Efficacy of UW Solution for 15-hr Heart Preservation

John G. Byrne, Michael Murphy, Wendel J. Smith, Gregory S. Couper, Robert F. Appleyard, Lawrence H. Cohn

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

University of Wisconsin solution (UW) has been demonstrated to improve donor heart preservation. During reperfusion, however, myocardial performance may still remain limited by neutrophil (PMN)-mediated injury, manifested by the "low-reflow" phenomenon and myocardial "stunning." Since PMN adhesion is an important mechanism of PMN-mediated injury, we tested whether blocking PMN adhesion molecule CD18 would enhance the efficacy of UW for 15-hr heart preservation. Rabbit hearts (n = 15) were arrested with, and preserved for 15 hr in, 4°C UW. After insertion of an left ventricular (LV) balloon, hearts were heterotopically transplanted into recipients pretreated with either intravenous (iv) saline (vehicle, n = 8) or iv anti-CD18 monoclonal antibody R15.7 (anti-CD18, n = 7). After 1 hr reperfusion the slope of the peak systolic pressure-volume (P-V) relation (Emax), the exponential coefficient (β), the volume-axis intercept (Vo) of the end-diastolic P-V relation, and the time constant of the exponential LV pressure decay after dP/dtmin (τ) were measured. Blood flow was measured with microspheres from which coronary vascular resistance (CVR) was calculated. Tissue %H2O was also measured. Between groups there were no significant differences in Emax (70.5 ± 6.1 vs 63.7 ± 6.0 mm Hg/ml, P > 0.05), β (3.3 ± 0.5 vs 4.3 ± 0.5, P > 0.05), Vo (-0.4 ± 0.1 vs -0.4 ± 0.2 ml, P > 0.05) or %H2O (81.3 ± 1.1 vs 80.0 ± 0.9, P > 0.05). However, compared to the vehicle group, the anti-CD18 group demonstrated a significant decrease in τ (162 ± 32 vs 64 ± 33 msec, P <0.05) and CVR (184.8 ± 50.7 vs 64.6 ± 14.5 U/g, P <0.05). These results demonstrate the attenuation of the low-reflow phenomenon and diastolic myocardial stunning by a monoclonal antibody which blocks PMN adhesion. We conclude that, despite successful 15-hr heart preservation with UW, myocardial performance remains limited by PMN-mediated reperfusion injury, which can be attenuated by blocking PMN adhesion molecule CD18 during reperfusion.

Original languageEnglish (US)
Pages (from-to)625-630
Number of pages6
JournalJournal of Surgical Research
Volume54
Issue number6
DOIs
StatePublished - Jun 1993
Externally publishedYes

Fingerprint

Reperfusion Injury
Myocardial Stunning
Reperfusion
Vascular Resistance
Monoclonal Antibodies
Blood Pressure
Wounds and Injuries
Ventricular Pressure
Microspheres
Neutrophils
Rabbits

ASJC Scopus subject areas

  • Surgery

Cite this

Prevention of CD18-Mediated Reperfusion Injury Enhances the Efficacy of UW Solution for 15-hr Heart Preservation. / Byrne, John G.; Murphy, Michael; Smith, Wendel J.; Couper, Gregory S.; Appleyard, Robert F.; Cohn, Lawrence H.

In: Journal of Surgical Research, Vol. 54, No. 6, 06.1993, p. 625-630.

Research output: Contribution to journalArticle

Byrne, John G. ; Murphy, Michael ; Smith, Wendel J. ; Couper, Gregory S. ; Appleyard, Robert F. ; Cohn, Lawrence H. / Prevention of CD18-Mediated Reperfusion Injury Enhances the Efficacy of UW Solution for 15-hr Heart Preservation. In: Journal of Surgical Research. 1993 ; Vol. 54, No. 6. pp. 625-630.
@article{0b0db8d7ba2c4d46811abc7fd1a9a630,
title = "Prevention of CD18-Mediated Reperfusion Injury Enhances the Efficacy of UW Solution for 15-hr Heart Preservation",
abstract = "University of Wisconsin solution (UW) has been demonstrated to improve donor heart preservation. During reperfusion, however, myocardial performance may still remain limited by neutrophil (PMN)-mediated injury, manifested by the {"}low-reflow{"} phenomenon and myocardial {"}stunning.{"} Since PMN adhesion is an important mechanism of PMN-mediated injury, we tested whether blocking PMN adhesion molecule CD18 would enhance the efficacy of UW for 15-hr heart preservation. Rabbit hearts (n = 15) were arrested with, and preserved for 15 hr in, 4°C UW. After insertion of an left ventricular (LV) balloon, hearts were heterotopically transplanted into recipients pretreated with either intravenous (iv) saline (vehicle, n = 8) or iv anti-CD18 monoclonal antibody R15.7 (anti-CD18, n = 7). After 1 hr reperfusion the slope of the peak systolic pressure-volume (P-V) relation (Emax), the exponential coefficient (β), the volume-axis intercept (Vo) of the end-diastolic P-V relation, and the time constant of the exponential LV pressure decay after dP/dtmin (τ) were measured. Blood flow was measured with microspheres from which coronary vascular resistance (CVR) was calculated. Tissue {\%}H2O was also measured. Between groups there were no significant differences in Emax (70.5 ± 6.1 vs 63.7 ± 6.0 mm Hg/ml, P > 0.05), β (3.3 ± 0.5 vs 4.3 ± 0.5, P > 0.05), Vo (-0.4 ± 0.1 vs -0.4 ± 0.2 ml, P > 0.05) or {\%}H2O (81.3 ± 1.1 vs 80.0 ± 0.9, P > 0.05). However, compared to the vehicle group, the anti-CD18 group demonstrated a significant decrease in τ (162 ± 32 vs 64 ± 33 msec, P <0.05) and CVR (184.8 ± 50.7 vs 64.6 ± 14.5 U/g, P <0.05). These results demonstrate the attenuation of the low-reflow phenomenon and diastolic myocardial stunning by a monoclonal antibody which blocks PMN adhesion. We conclude that, despite successful 15-hr heart preservation with UW, myocardial performance remains limited by PMN-mediated reperfusion injury, which can be attenuated by blocking PMN adhesion molecule CD18 during reperfusion.",
author = "Byrne, {John G.} and Michael Murphy and Smith, {Wendel J.} and Couper, {Gregory S.} and Appleyard, {Robert F.} and Cohn, {Lawrence H.}",
year = "1993",
month = "6",
doi = "10.1006/jsre.1993.1096",
language = "English (US)",
volume = "54",
pages = "625--630",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "6",

}

TY - JOUR

T1 - Prevention of CD18-Mediated Reperfusion Injury Enhances the Efficacy of UW Solution for 15-hr Heart Preservation

AU - Byrne, John G.

AU - Murphy, Michael

AU - Smith, Wendel J.

AU - Couper, Gregory S.

AU - Appleyard, Robert F.

AU - Cohn, Lawrence H.

PY - 1993/6

Y1 - 1993/6

N2 - University of Wisconsin solution (UW) has been demonstrated to improve donor heart preservation. During reperfusion, however, myocardial performance may still remain limited by neutrophil (PMN)-mediated injury, manifested by the "low-reflow" phenomenon and myocardial "stunning." Since PMN adhesion is an important mechanism of PMN-mediated injury, we tested whether blocking PMN adhesion molecule CD18 would enhance the efficacy of UW for 15-hr heart preservation. Rabbit hearts (n = 15) were arrested with, and preserved for 15 hr in, 4°C UW. After insertion of an left ventricular (LV) balloon, hearts were heterotopically transplanted into recipients pretreated with either intravenous (iv) saline (vehicle, n = 8) or iv anti-CD18 monoclonal antibody R15.7 (anti-CD18, n = 7). After 1 hr reperfusion the slope of the peak systolic pressure-volume (P-V) relation (Emax), the exponential coefficient (β), the volume-axis intercept (Vo) of the end-diastolic P-V relation, and the time constant of the exponential LV pressure decay after dP/dtmin (τ) were measured. Blood flow was measured with microspheres from which coronary vascular resistance (CVR) was calculated. Tissue %H2O was also measured. Between groups there were no significant differences in Emax (70.5 ± 6.1 vs 63.7 ± 6.0 mm Hg/ml, P > 0.05), β (3.3 ± 0.5 vs 4.3 ± 0.5, P > 0.05), Vo (-0.4 ± 0.1 vs -0.4 ± 0.2 ml, P > 0.05) or %H2O (81.3 ± 1.1 vs 80.0 ± 0.9, P > 0.05). However, compared to the vehicle group, the anti-CD18 group demonstrated a significant decrease in τ (162 ± 32 vs 64 ± 33 msec, P <0.05) and CVR (184.8 ± 50.7 vs 64.6 ± 14.5 U/g, P <0.05). These results demonstrate the attenuation of the low-reflow phenomenon and diastolic myocardial stunning by a monoclonal antibody which blocks PMN adhesion. We conclude that, despite successful 15-hr heart preservation with UW, myocardial performance remains limited by PMN-mediated reperfusion injury, which can be attenuated by blocking PMN adhesion molecule CD18 during reperfusion.

AB - University of Wisconsin solution (UW) has been demonstrated to improve donor heart preservation. During reperfusion, however, myocardial performance may still remain limited by neutrophil (PMN)-mediated injury, manifested by the "low-reflow" phenomenon and myocardial "stunning." Since PMN adhesion is an important mechanism of PMN-mediated injury, we tested whether blocking PMN adhesion molecule CD18 would enhance the efficacy of UW for 15-hr heart preservation. Rabbit hearts (n = 15) were arrested with, and preserved for 15 hr in, 4°C UW. After insertion of an left ventricular (LV) balloon, hearts were heterotopically transplanted into recipients pretreated with either intravenous (iv) saline (vehicle, n = 8) or iv anti-CD18 monoclonal antibody R15.7 (anti-CD18, n = 7). After 1 hr reperfusion the slope of the peak systolic pressure-volume (P-V) relation (Emax), the exponential coefficient (β), the volume-axis intercept (Vo) of the end-diastolic P-V relation, and the time constant of the exponential LV pressure decay after dP/dtmin (τ) were measured. Blood flow was measured with microspheres from which coronary vascular resistance (CVR) was calculated. Tissue %H2O was also measured. Between groups there were no significant differences in Emax (70.5 ± 6.1 vs 63.7 ± 6.0 mm Hg/ml, P > 0.05), β (3.3 ± 0.5 vs 4.3 ± 0.5, P > 0.05), Vo (-0.4 ± 0.1 vs -0.4 ± 0.2 ml, P > 0.05) or %H2O (81.3 ± 1.1 vs 80.0 ± 0.9, P > 0.05). However, compared to the vehicle group, the anti-CD18 group demonstrated a significant decrease in τ (162 ± 32 vs 64 ± 33 msec, P <0.05) and CVR (184.8 ± 50.7 vs 64.6 ± 14.5 U/g, P <0.05). These results demonstrate the attenuation of the low-reflow phenomenon and diastolic myocardial stunning by a monoclonal antibody which blocks PMN adhesion. We conclude that, despite successful 15-hr heart preservation with UW, myocardial performance remains limited by PMN-mediated reperfusion injury, which can be attenuated by blocking PMN adhesion molecule CD18 during reperfusion.

UR - http://www.scopus.com/inward/record.url?scp=0027361924&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027361924&partnerID=8YFLogxK

U2 - 10.1006/jsre.1993.1096

DO - 10.1006/jsre.1993.1096

M3 - Article

C2 - 8105148

AN - SCOPUS:0027361924

VL - 54

SP - 625

EP - 630

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 6

ER -